Ludwig @harvard.edu’s @jennyhogstrom.bsky.social presented her work @ #AACR25 on a newly identified metabolic mechanism of resistance to a targeted therapy in hormone receptor-positive breast cancer.

The recording of our recent webinar, "Enhancing tumor microenvironment research: Simultaneous isolation of patient-derived organoids and matching CAFs" by @jennyhogstrom.bsky.social, moderated by Dr. Ilgen Mender, is now available! You can access it here! #Webinar #LifeSciences #CancerResearch

What a great #aacr grantee reception. Thoroughly enjoyed all the posters. I’m extremely greatful to AACR and AstraZeneca for funding my research.

📢 Bio-protocol Webinars present: Enhancing tumor microenvironment research: Simultaneous isolation of patient-derived organoids and matching CAFs 🔗 Register Now! Join us on: 🗓 Date: April 9, 2025 ⏰ Time: 11:00 AM EST Speaker: @jennyhogstrom.bsky.social Moderator: Ilgen Mender #webinar #cancer

Check out this Q&A from the latest Ludwig Link, in which Ludwig @harvard.edu’s @jennyhogstrom.bsky.social tells us about her vocational and avocational passions: bit.ly/40ZYmnH

Our very detailed protocol for CAF and PDO isolation is out

Happy holidays

Our VERY detailed protocol of generating HR+ breast cancer organoids and matching CAFs is out: bio-protocol.org/e5160 This is a follow-up to @jennyhogstrom.bsky.social last paper, just with more details to help everyone generate these organoid CAF co-cultured and to move cancer research forward!